Dain Rauscher Wessels Announces Investment Opinion on AZA, ARDM, CIMA, ELN, INHL, NOVN, PPCO and WPI.Business Editors & Analysts NOTE TO EDITORS: The following is an investment opinion issued by Dain Rauscher Wessels MINNEAPOLIS--(BUSINESS WIRE)--April 25, 2001 Dain Rauscher Wessels Report Finds Value in Expanding Drug Delivery Industry The drug delivery industry is taking a growing role in improving the therapeutic features of pharmaceuticals. The $7.1 billion industry combines skills in formulation with an understanding of life sciences in order to optimize drugs. "Companies are developing a growing array of novel technologies that improve the value of pharmaceutical discoveries," said Louis Webb, equity analyst at Dain Rauscher Wessels. "We believe this sector offers attractive investment opportunity related to the level of value it brings to the marketplace and its capacity for growth." Webb recently issued a report, "Drug Delivery Systems; Improving Drugs and Competitive Advantage," which details eight companies he recently initiated coverage on: ALZA Corp. (AZA), Aradigm (ARDM), CIMA Labs, Inc. (CIMA), Elan Corp. (ELN Noun 1. ELN - a Marxist terrorist group formed in 1963 by Colombian intellectuals who were inspired by the Cuban Revolution; responsible for a campaign of mass kidnappings and resistance to the government's efforts to stop the drug trade; "ELN kidnappers target ), Inhale Therapeutic Systems (INHL INHL Institute for Nursing Healthcare Leadership ), Noven Pharmaceuticals (NOVN), Penwest Pharmaceuticals (PPCO PPCO Phillips Petroleum Company PPCO Provisioning Principal Contracting Office PPCO Penwest Pharmaceutical Company ) and Watson Pharmaceuticals Watson Pharmaceuticals, Incorporated (NYSE: WPI) is the 5th largest pharmaceutical company in the United States based on number of prescriptions dispensed. Based in Corona, California, Watson's Generics division markets over 150 pharmaceutical product families, including one of the (WPI WPI - Worcester Polytechnic Institute ). "Our coverage focuses on companies capable of long-term earnings growth because of their attractive commercial products or because they are near the point of entering a profit-sustaining phase," Webb said. Institutional investors interested in receiving the 103-page report should contact their Dain Rauscher Wessels salesperson. Media interested in receiving the report should call 612-371-2239. Dain Rauscher Wessels, a division of Dain Rauscher Incorporated, includes equity research, equity trading In finance, equity trading is the buying and selling of company stock shares. Shares in large publicly-traded companies are bought and sold through one of the major stock exchanges, such as the New York Stock Exchange, London Stock Exchange or Tokyo Stock Exchange, which serve as , institutional equity sales and corporate finance. The division's 40 analysts focus on five industries: consumer, energy, financial services, health care and technology. Currently, the analysts follow nearly 500 companies. The division, which employs 450 people, has offices in Austin, Texas; Boston; Dallas; Houston; Memphis, Tenn.; Menlo Park, Calif.; Minneapolis; New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. ; Paris; San Francisco; Seattle; and Tel Aviv, Israel(a). Dain Rauscher Corporation, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Royal Bank of Canada Bank of Canada Canada's central bank, established under the Bank of Canada Act (1934). It was founded during the Great Depression to regulate credit and currency. The Bank acts as the Canadian government's fiscal agent and has the sole right to issue paper money. (NYSE NYSE See: New York Stock Exchange :RY), is one of the nation's largest full-service securities firms with 1,200 investment executives and 3,800 employees. The company's broker-dealer, Dain Rauscher Incorporated, serves individual investors and small business owners through offices predominantly in the western half of the United States, and capital markets and correspondent clients in select U.S. and international markets. Founded in 1909, Dain Rauscher Incorporated is a member of the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. and other major securities exchanges, as well as the Securities Investor Protection Corp. The company's headquarters are located at Dain Rauscher Plaza, 60 S. Sixth St., in Minneapolis. Dain Rauscher Incorporated makes a market in Aradigm Corporation; CIMA Labs INC.; Inhale Therapeutic Systems, Inc.; Noven Pharmaceuticals, Inc., Penwest Pharmaceuticals, Inc.; Amgen Inc.; and Biogen, Inc. and may act as principal with regard to sales or purchases of these securities. In addition, Dain Rauscher Incorporated managed or co-managed a public offering of the securities of Medtronic, Inc. within the past three years. Additional information on the securities mentioned is available on request. This does not purport to be a complete statement of all material facts related to any company, industry, or security mentioned. The information provided, while not guaranteed as to accuracy or completeness, has been obtained from sources believed to be reliable. The opinions expressed reflect our judgment at this time and are subject to change without notice and may or may not be updated. DRI See Digital Research. , its officers, directors, affiliates, and/or employees (including the authors of this report) may from time to time have a long or short position in publicly or privately issued securities of companies mentioned or derivatives thereof and may sell or buy such securities for their own or related accounts. This notice shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which said offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. (a)Strategic alliance with Tamir Fishman & Co. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion